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Leptospirosis is one of the most widespread and pervasive
zoonotic bacterial diseases worldwide. Current global esti-
mates indicate thatmore than 500 000 cases of human disease
occur annually and that under-reporting is likely to be substan-
tial especially in endemic regions.1 Human leptospirosis, caused
by infection with pathogenic Leptospira bacteria, can range
from a mild, self-limiting or subclinical infection, to a severe,
life-threatening disease.2 Patients typically present with sud-
den onset, non-specific febrile illness, which progresses to a
severe, life-threatening disease in approximately 10% of
cases. Multiple organ systems can be affected and disease
manifestations include icterus, renal failure and haemorrhage
(Weil’s disease), severe pulmonary haemorrhage syndrome
(SPHS) or meningitis. The reported case fatality ratio for icteric
disease ranges from 5–15% but estimates are higher (.50%)
for patients with SPHS.3
Leptospira infection occurs following direct or indirect contact
with the urine of an infected animal. More than 250 identified
pathogenic serovars have been identified that can infect a wide
variety of mammal species, ranging from domestic animals to
rodents and other wildlife.3 Leptospirosis is also an important vet-
erinary problem that is often overlooked. Infection in production
animals, especially cattle and pigs, can lead to abortions, infertil-
ity, and milk and meat production losses.4 As a zoonotic disease,
the epidemiology of human and animal leptospirosis are inti-
mately linked. However, determining the sources and transmission
routes for human infection can be challenging, especially where
multiple potential animal hosts co-exist. Environmental persist-
ence of Leptospira bacteria further complicates the epidemiology
of leptospirosis, particularly in tropical areas where climatic condi-
tions favour prolonged survival.3 Disease outbreaks have been
associated with heavy rainfall and flooding, poor sanitary condi-
tions in slum environments, and following water-sport events
held in contaminated water sources.5
In tropical regions of the world, including South-East Asia and
South America, leptospirosis is recognised as an important cause
of human febrile illness.2 In contrast, there is little awareness of
leptospirosis in Africa, where climatic and environmental condi-
tions are also predicted to support zoonotic disease transmission.
Leptospirosis has not always been neglected in Africa and the dis-
ease has a fascinating history on the continent. Following the dis-
covery of leptospirosis in Japan in the early twentieth century,
Africa became a hotspot of leptospirosis research as microbiolo-
gists worked to differentiate the causal agents of Weil’s disease
and yellow fever (flavivirus).6 In the mid-twentieth century, a
group of prolific European researchers, including Van Riel in
Belgian Congo,7 Mailloux in Morocco8 and De Geus in Kenya9, gen-
erated awealth of data on human and animal leptospirosis on the
continent that has remained unrivalled in either scope or volume.
Despite the technological and logistical challenges faced by these
researchers, many Leptospira serovars of African origin were first
isolated and identified during this period.
Unfortunately, current research into leptospirosis in Africa is
relatively fragmented with little to no recent data available on
human disease inmany countries.10 Poor public health infrastruc-
ture coupled with conflict and economic or political instability
have inevitably contributed to gaps in surveillance, particularly
from Western and Central Africa. Challenges that limit our ability
to detect and diagnose leptospirosis in low-resource settings have
further restricted disease surveillance efforts. Little is known
about risk factors for endemic infection in either human or animal
populations. Laboratory diagnosis of infection can be challenging
even in high-income settings, and may not be feasible in under-
resourced hospitals and laboratory facilities. Furthermore, acute
leptospirosis is often clinically indistinguishable from other causes
of febrile illness in tropical areas, such as malaria or dengue fever,
and is rarely considered as a differential diagnosis by clinicians.
Studies in Tanzania have demonstrated that leptospirosis is an
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important cause of severe febrile illness in the region but is typic-
ally diagnosed and treated as malaria.11,12 Given that fever is one
of the most common reasons for patients to seek health care in
Africa, misdiagnosis of leptospirosis could represent a major pub-
lic health challenge.
Promoting clinician awareness of leptospirosis is one of
themost essential and achievable interventions for tackling lepto-
spirosis in Africa. Leptospirosis is treatable with antimicrobials,
including those recommended in international guidelines for the
empirical treatment of severe febrile illness in low-resource areas.
Therefore, improving clinician awareness of the differential diag-
noses for febrile illness, and treatment recommendations
for malaria-negative febrile patients, could have a real impact
on the care of leptospirosis patients in the future.13 Preventive
measures in animal populations need to be considered and
assessed alongside improved human case recognition and man-
agement. Leptospira infections are widespread in livestock in
Africa,10 and livestock vaccinations do exist for some serovars.
Effective vaccination use in high-risk animal populations could
potentially generate substantial benefits for both human and ani-
mal health by reducing Leptospira infection in animal source
populations, minimising livestock productivity losses and protect-
ing vulnerable farming communities with limited access to health
services.14
Raising the profile of leptospirosis in Africa with national and
international policymakers is also of paramount importance to
tackle this neglected but important public health problem. WHO
Leptospirosis Burden Epidemiology Reference Group (LERG) and
the Global Leptospirosis Environmental Action Network (GLEAN)
are working to provide a robust global evidence base to policy-
makers and researchers. The International Leptospirosis Society,
which holds its 9th Biennial meeting in Indonesia (7–10 October
2015; http://ils2015.centrid.org/), plays an important role in dis-
seminating research findings and promoting disease awareness.
The International Leptospirosis Society provides invaluable sup-
port for leptospirosis researchers around the world with growing
interest and enthusiasm for supporting work in Africa.
To understand and quantify the burden and impact of lepto-
spirosis in Africa, we need to rekindle our interest in integrated
human and animal leptospirosis research on the continent. As a
zoonotic disease, the control of human leptospirosis is unlikely
to be effective without also considering control in animal popula-
tions. Encouragingly, the ‘One Health’ ideology, which brings
together researchers from the fields of medicine, veterinarymedi-
cine, sociology and environmental science, is being embraced
with enthusiasm in Africa.15 With African researchers poised to
lead a global trend in zoonotic disease research, exciting oppor-
tunities exist to reverse the neglect of leptospirosis in the
African continent.
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